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Abstract
Background: Evidence is urgently needed from complex emergency settings to support efforts to respond to the
increasing burden of diabetes mellitus (DM). We conducted a qualitative study of a new model of DM health care
(Integrated Diabetic Clinic within an Outpatient Department [IDC-OPD]) implemented by Médecins Sans Frontières
(MSF) in Mweso Hospital in eastern Democratic Republic of Congo (DRC). We aimed to explore patient and
provider perspectives on the model in order to identify factors that may support or impede it.
Methods: We used focus group discussions (FGDs; two discussions, each with eight participants) and individual
semi-structured qualitative interviews (seven patients and 10 staff) to explore experience of and perspectives on the
IDC-OPD. Participants were recruited purposively to represent a range of DM disease severity and staff functions
respectively, and to ensure the age and gender distribution was representative of the population of DM patients
registered in the clinic. Data were coded in NVivo10© and analysed using an inductive thematic approach.
Results: There appears to be little awareness surrounding DM in patient communities, resulting in delays
presenting to hospital. Patients describe their first reactions to symptoms as fear and confusion, often assuming
symptoms are of another disease (e.g. HIV/AIDS). They often express disbelief that they could have DM (e.g. stating
DM is a ‘rich man’s disease’) and lack acceptance that there is no cure. Patients experienced difficulty travelling to
appointments, exacerbated by flare-ups in the conflict. Providing psycho-social and sensitisation activities in a
group setting appears to offer an opportunity for patients to support each other in their effort to adhere to drug
treatment and follow-up appointments. All patients reported great difficulty in adhering to the recommended diet,
which was viewed as unaffordable and unavailable, and fear that this would be the biggest obstacle to maintaining
their drug treatment (as treatment must be taken with food).
Conclusion: Our findings emphasize the importance of community awareness of DM and the value of treatment
support, including psychosocial and educational support to DM patients and their families, and culturally sensitive,
low-cost dietary advice, to ensuring the adoption and maintenance of DM treatment.
Keywords: Diabetes mellitus, Treatment, Conflict, Non-communicable diseases NCDs, Humanitarian, Emergency,
Low- and middle-income countries LMICs
Background
The global burden of non-communicable diseases
(NCDs) is growing rapidly worldwide, and particularly in
low-and middle-income countries (LMICs) [1, 2]. This is
especially true of diabetes mellitus (DM), one of the
most common NCDs, which has increased globally by
almost 45% since 1990 [3]. The largest proportional
increase expected in adult diabetes cases, 90.5% by 2030,
is expected in the World Health Organization (WHO)
African Region [4].
The risk of mortality and morbidity from DM is sig-
nificant, both from acute events and from long-term
micro-and macro-vascular complications. Early detec-
tion and consistent treatment with drug therapy can
significantly reduce these risks [5, 6]. Yet, in countries at
all levels of development, a substantial proportion of
people with DM go undetected and untreated [7]. In
countries with poorly co-ordinated and fragmented
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health systems, levels of premature mortality from DM
are particularly high [8–10]. These problems are com-
pounded in complex humanitarian emergency settings
where health systems have broken down [9] and the
accessibility of primary care, availability of trained staff,
and co-ordination between health facilities required for
effective DM interventions are compromised.
Despite the growing issue of DM and other NCDs
globally, and their increased relevance among conflict-
affected populations [11], there is a dearth of evidence
on how interventions should be delivered in complex
emergency settings [12], and little attention has been
given to NCDs by humanitarian actors [13, 14]. While
the experience of delivering DM care in a conflict setting
in Mali has been described [14], and the effectiveness of
a DM programme in Palestine assessed [15–17], the
factors impeding or supporting the effectiveness of such
programmes have not been evaluated. Such evidence is
urgently needed from complex emergency settings to
support the efforts of humanitarian agencies in respond-
ing to DM. We conducted a qualitative study of a new
model of DM health care implemented by Médecins
Sans Frontières (MSF) in the Democratic Republic of
Congo (DRC). We aimed to explore the patient and
provider perspectives on the model in order to identify
factors that may support or impede it.
Methods
Research setting
Since 2008, MSF has offered primary and secondary
health care in Mweso health zone in the Health District of
Masisi, North Kivu Province, eastern DRC. Mweso is a
rural, low-income region affected by the conflict between
government and rebel forces that has persisted since the
end of the Second Congo War in 2003. Mweso zone has
an estimated population of 365,000 people, including 17
camps for internally displaced people. MSF, in collabor-
ation with the local Ministry of Health (MoH), supports
health services in the hospital in Mweso and in four of 23
primary health care clinics in Masisi.
Mweso Hospital serves a catchment area of an esti-
mated 145,000 people, but the realistic number of bene-
ficiaries in the immediate catchment area is likely closer
to 65,000. There are 130,000 out-patient consultations
per year and 5000 in-patient admissions. There are no
data on the prevalence of diabetes in this specific popu-
lation, but the International Diabetes Federation esti-
mates a DM prevalence of 5.3% for DRC overall [18].
Until March 2015, Mweso Hospital routinely treated DM
patients presenting with acute complications. However,
there was a lack of clinical guidance, standard operating
procedures (SOPs), and appropriately trained staff. In
March 2015, a new model of DM care was implemented by
MSF. The Integrated Diabetic Clinic within an Outpatient
Department (IDC-OPD) is based on simplified context-
adapted clinical guidelines, clinical SOPs, adapted pa-
tient counselling and support materials, and one-off
staff training by a diabetologist. IDC-OPD is a nurse-
led, multi-disciplinary model of care adapted to the
specific setting of Mweso Hospital. The clinical guide-
lines were developed for the Mweso setting based on
WHO, International Diabetes Association, National
Institute of Clinical Excellence and MSF guidelines,
with input from a diabetes specialist and experienced MSF
clinicians. Diabetes educational tools were developed for
Mweso based on tools developed by Diabetsante (Mali).
The service is managed by a nurse supervisor who
oversees the running of the clinic. Care on clinic days is
also provided by a nursing assistant, two doctors who
provide medical support and see referred patients, a
nutritionist, an information, education and counselling
officer, and a psycho-social support officer. Most pa-
tients enter the clinic cohort after discharge from the in-
patient ward, where DM is usually diagnosed following
acute presentation. A small proportion are diagnosed
in Mweso out-patient-department or referred from
external clinics. Every patient is recorded in the clinic
register and has an individual patient file. Outpatient
clinical procedures involve new patient assessment,
monthly nurse-led follow-up appointments, and 6-
month medical review. More details on the model are
in Additional file 1: Appendix A.
At the time this study was conducted there were 107
active patients of 177 ever registered. The median age of
the cohort was 45 years, and 19 were younger than
20 years. Based on the large proportion of younger
patients with high insulin requirements, who present
with recurrent non-ketotic hyperglycaemia (and early
onset of chronic complications such as blindness), we
suspect that a significant proportion of the cohort have
malnutrition-modulated diabetes. However, the majority
of the cohort have typical type 2 disease, with a handful
of type 1 cases.
Study design
We conducted a qualitative study as part of a mixed
methods evaluation using the RE-AIM framework [19].
The RE-AIM framework acknowledges that public
health interventions act on multiple levels (e.g. individ-
ual, health-care provider, institutional) and that their
impact relies on the combined effect on five evaluative
dimensions: Reach (proportion of population affected by
the programme); Efficacy (positive and negative out-
comes of the programme); Adoption (degree of par-
ticipation in programme); Implementation (degree to
which programme is implemented as intended); and
Maintenance (institutionalization of the programme).
The qualitative element of RE-AIM seeks to identify
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factors that may support or impede the achievement
of these dimensions with respect to the IDC-OPD
programme. In addition to the qualitative study, the
full evaluation of the IDC-OPD includes quantitative
analysis of routine programmatic and costing data,
and a cross-sectional survey of prevalence and service
use. The findings of those studies will be reported
separately.
Data collection
We used a combination of focus group discussions
(FGDs) and individual semi-structured qualitative inter-
views to explore patient and staff experience of and
perspectives on the IDC-OPD.
We held two FGDs with eight patients each, to assess
the appropriateness of the general categories included in
our topic guide. We then conducted semi-structured
individual interviews, to enable in-depth exploration of
an individual’s perception of a particular phenomenon
[20]. Patients were recruited purposively to represent a
range of DM disease severity and staff functions respect-
ively, and to ensure the age and gender distribution of
the sample was broadly representative of the population
of DM patients registered in the clinic. All staff involved
in the DM clinic were recruited for interviews. (Staff
involved in the clinic happened to be all male, which,
based on our experience, is not uncommon in DRC).
Eligible participants were provided with a full explan-
ation of the study objectives and given an information
sheet with these details. It was also explained to them
that their participation in the study was strictly volun-
tary and would not impact on their access to care. None
of the invited eligible participants refused to participate
in the study and all participants signed an informed
consent form. We conducted individual interviews until
data saturation was achieved (i.e. additional interviews
did not uncover new themes related to our research
question). The final number of individual interview par-
ticipants was seven patients and 10 staff members.
(Table 1) As we were interested in over-arching themes,
or meta-themes, we were able to achieve saturation with
a smaller sample size than would normally be needed
for finer-grained themes [21].
The topic guides first covered background information
with regard to the patients’ experience of DM, or the staff
member’s role in the IDC-OPD, and then included
prompts related to each of the five RE-AIM dimensions
(e.g. barriers to accessing testing for DM, information and
support provided to patients to encourage adherence,
challenges to maintaining adherence, unintended negative
consequences of treatment). The complete final English
version of the topic guides for the FGDs, patient inter-
views, and staff interviews can be found in Additional
file 1: Appendix B, C, and D respectively. All interviews
were conducted in a private room and in the partici-
pant’s spoken language (Swahili, French, or English),
by a trained researcher. Interviews in Swahili and
French were conducted by MB (male, Assistant to the
Humanitarian Affairs Office at MSF Goma); interviews
in English were conducted by AM (female, public health
researcher at the London School of Hygiene and Tropical
Medicine). Interviews were audio-recorded, transcribed,
and, where necessary, translated into English by trained
third-party researchers not otherwise involved in the
study.
Analysis
Data were coded in NVivo10© and analysed by AM
using an inductive thematic approach. Inductive the-
matic analysis involves coding data for emerging themes
and concepts without trying to accommodate a hypo-
thetical framework, and is thus ‘data driven’ and reflexive
[22, 23]. Analysis followed the steps to thematic analysis
outlined by Braun and Clarke [22]. First, transcripts were
read in their entirety and initial open codes (e.g. ‘Fear of
diagnosis‘, ‘Staff pride in programme‘) were generated.
Second, all coded excerpts were organised into a process
of selective coding where core codes were developed ap-
plying constant comparative analyses toward categories
(e.g. ‘Acceptance of DM treatment', ‘Staff investment and
capacity”). Finally, organic identification and develop-
ment of latent patterns, to generate themes applying
principles of grounded theory (meaning emergent codes
Table 1 Study participants
Patients Approximate age Gender
P01 16 male
P02 70 female
P03 46 male
P04 54 female
P05 58 male
P06 60 male
P07 49 male
Staff Role Gender
S01 Consultation nurse male
S02 Psycho-social support officer male
S03 Information, education and counselling officer male
S04 Local MoH doctor male
S05 Nurse supervisor male
S06 Mental health officer male
S07 Nutritionist male
S08 MSF doctor male
S09 MSF doctor male
S10 MSF doctor male
MoH Ministry of Health, MSF Médecins Sans Frontières
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and themes were based in the data derived from inter-
views) were checked with reflexive practice to ensure
against the insertion of preconceived assumptions.
These themes were related back to the research question
and to existing literature. Negative cases or exceptions were
examined to test emerging themes and to analyse why these
cases were different. Findings were scrutinized by two team
members to enhance inter-rater reliability and analytic
credibility. We report our findings following the ‘Consoli-
dated Criteria for Reporting Qualitative Research’ checklist
for transparency [24].
Results
The final sample of study participants for patients (P)
and staff (S) are presented in Table 1. Two dominant
themes emerged, highlighting factors that may support
or impede the reach, efficacy, adoption, implementation,
and maintenance of the IDC-OPD model: i) community
awareness, knowledge and family support; and ii)
sustainable treatment approach. These themes and the
categories and codes that they were drawn from are
shown in Table 2. We elaborate on key findings within
each of these themes below.
Community awareness, knowledge, and family support:
empowerment, acceptance, and adherence to DM treatment
There appears to be very little awareness surrounding
DM in patient communities, resulting in delays before
patients present to the hospital with symptoms. Pa-
tients describe their first reactions to their symptoms
as fear and confusion, often assuming these are symp-
toms of another disease of which they are more aware
(e.g. HIV/AIDS).
" I started feeling thirsty for water, then I started losing
weight, people started saying that I have AIDS. So I
started feeling scared, people were saying that I would
die soon.....I didn’t know what was affecting me and I
would have just died. They saw the symptoms because
I lost a lot of weight and many people were confused.
If nobody would have told me I would have continued
the same way until death." (P01, male)
Seeking care from a traditional healer in the first in-
stance appears common, and those who eventually make
it to the IDC-OPD often only do so because they hear
about the programme by chance, suggesting that there is
likely a much larger proportion of diabetes sufferers who
are not being reached by the IDC-OPD.
"I was home then I started feeling bad. I was passing
urine frequently and felt weak.
I went to seek help from herbalists and was given
herbal medicine. I kept taking it but was not
improving. Later I met a friend who advised me to
come to Mweso." (P02, female)
The reaction described by patients upon receiving a DM
diagnosis suggests fear and denial of their condition.
"I thought I was going to die. I despaired and felt
hopeless. They said it’s incurable. I just knew I would
die." (P04, female)
"There and then I felt fear. I had been told diabetes is
for rich people. But now me, a poor man? I was afraid.
I was afraid because diabetes is an expensive illness
Table 2 Coding framework
Theme Category Codes
Undermine programme effectiveness Promote programme effectiveness
Community awareness,
knowledge and family
support
Acceptance of DM
Adherence to DM treatment
Knowledge
Accessibility of treatment
Ignorance regarding DM
Word-of-mouth only DM awareness
Reliance on traditional healers
Fear of diagnosis
Feeling of emasculation among
men relating to diagnosis
Recommended foods difficult to obtain,
expensive
Transportation to clinic challenging in
conflict
Long distance to clinic
Perception of traditional medicines as
more effective
Acceptance of chronic nature of disease
View of medicine as the difference
between life and death
Awareness of consequences of not
treating
Support of family in DM diet and
treatment adherence
Bonding with other DM patients
Appreciation of importance of regular
appointments
Patient education as empowerment
Sustainable treatment
approach
Implementation of DM
programme
Staff investment and capacity
Ownership and certainty of
programme
Maintenance of DM programme
Heavy workload for staff compromises
quality
Low expectations for programme capacity
No dedicated programme resources
Dependence on NGO to maintain programme
Low institutional investment in programme
Staff pride in programme
Motivation from increased skills and
responsibility
DM diabetes mellitus, NGO non-governmental organisation
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for the rich. What was I supposed to do in my
poverty?" (P06, male)
They often express disbelief that they could have DM
(e.g. that DM is a ‘rich man’s disease’) and lack accept-
ance that there is no cure for their condition. The
patients that we interviewed represent those that have
overcome this fear and disbelief to return to the IDC-
OPD for treatment; however, interviews with the staff
responsible for the IDC-OPD clinic suggest that a sig-
nificant number of patients do not return to the clinic
after being diagnosed, often seeking a ‘cure’ from trad-
itional healers rather than facing the chronic nature of
their disease.
"After diagnosis...they (the patients) do not want to
accept that 'ok, this is the problem I have'. There is
also a feeling of guilt, they will feel guilty 'where did I
pick up this disease?'...Commonly, when we diagnosis
a person, they exhibit these feelings. Either they will
refuse, 'no this is not possible, how did I get this
disease? Where did I get it? Did she give me this
disease?' Because some patients say 'maybe it is
someone who contaminated me with this disease.'
Because, from the beginning, they do not have good
information about the disease." (S06)
"When they go back home, the patient may well be
influenced by the traditional practitioners, by telling
him that he will cure him. And then, he thinks he
must be cured. Why wouldn’t he? He believes the
healer. We say something different; we say it is an
incurable disease yet it is a disease that you can
control. It’s easier for him to listen to the other
message that gives him hope for cure. This is his
ultimate goal: cure. " (S02)
"Unfortunately, there was a case who went for
indigenous products... This is just one example we give
to the other patients..He thought he was cured with
indigenous products; we had screened him and started
him on pharmaceutical medication and then he was
sold some tradi-practitioners treat. He left and
remained stable for around two years, I don’t know
how, miraculously… But complications set in and
when he came in, he had such bruises we had to
amputate him. Now he is in the clinic. "(S08)
Providing psycho-social and sensitisation activities in a
group setting appears to offer an opportunity for pa-
tients to support each other in their effort to adhere to
drug treatment and follow-up appointments. Patients
reported creating relationships with others in the IDC-
OPD and coming to clinic appointments together.
"At the beginning, it may frustrate the patient. But,
with continued visits and because he meets other
patients, at the second, third visit, he feels much
better. He is not alone. The other patients are doing
fine. This helps him continuing with what we provide
in the programme." (S04)
Patients who had come to the clinic also reported feel-
ing that their family had accepted their condition and
were helping them to manage it, which suggests that
family support is an important element of adhering to
dietary treatment regimens. Yet interviews with both pa-
tients and staff suggested that ensuring family support
for, and understanding of, DM is challenging in early
stages post-diagnosis and may act as a roadblock to
maintenance of the IDC-OPD if not achieved. At times
the threat to family support appears to be related to gen-
der roles in the home, with male patients expressing
anxiety on the part of their family about losing the fam-
ily breadwinner. According to interviews with staff, the
temptation among patients to seek a more effective ‘cure’
for diabetes outside the IDC-OPD persists even after
treatment at the clinic is initiated, resulting in patient at-
trition. The themes of patient empowerment from group
counselling activities and family support are illustrated
in quotations from staff and patient interviews below.
Interviewer(I): "How about your wife, how do you think
she is handling your condition?"
Patient (P): "She gets discouraged. She wonders for how
long this will continue. She figures I am already gone,
living on medicines all my life. It brings her worry. But
I cannot stop injecting myself....The diet, it brings a lot
of strife. Because she has to prepare her food with the
children, then prepare mine. It brings many quarrels.
We just live by the grace of God." (P06, male)
All patients interviewed in our research reported great
difficulty in adhering to the diet that is recommended to
them by the IDC-OPD nutrition team. Interviews revealed
feelings of helplessness in trying to maintain a diet that is
viewed as unaffordable and unavailable, and fear that this
will be the biggest obstacle to maintaining their drug treat-
ment (as treatment must be taken with food).
"I would follow the diet happily, but unfortunately the
foods I am asked to eat are very difficult to find. We
have the red bananas which I can only eat a little of.
The right food to eat is difficult to get. It’s not easily
available where I come from." (PO3, male)
P: "I do my best to get food so as to take my medicine.
But, diabetes is a rich man’s disease"
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I: "Do you stop taking medication when you have no
food? "
P: "Yes, I sometimes stop. This disease is expensive.
"(P04, female)
This challenge is compounded by the fact that patients
feel their dietary restrictions cause a burden to their
households, who have to create separate meals for them.
" It (this disease) is difficult because it requires two
meals in the family. Sometimes you have no money to
afford the meals. It’s more expensive and the income is
less. Because they have to separate my meals. People
who inject, they need to eat; they need to have
certainty of meals. When they get home they worry,
thinking they may die due to lack of food. Majority of
us are very poor, sometime you find you have nothing,
you get discouraged because you have medicines but
not the food, especially the ones who inject. You must
eat before injecting" (P05, male)
The Mweso IDC-OPD is the only DM clinic in North
Kivu, DRC. As such, many patients travel to Mweso from
far distances, sometimes up to 4 or 5 h away to acquire
medications. Travel distance to the clinic appears to
present an obstacle to patients maintaining clinic appoint-
ments and acquiring medication for treatment adherence,
"I: How do you find coming here for every appointment
to collect medicines? Is it easy for you? Do you
encounter any difficulties?
P: It’s difficult, every day selling bitter vegetables
and paying the fare to this place regularly. It’s not
easy. It’s tiring. You need flour and vegetables for
food, yet you are forced to have money for your
fare here." (P02, female)
"I come for appointments from (place name). When I
have money, I pay for a ride. Like today, I walked to
Kichanga then found someone assisted me with some
money and I took transport to here. When I have
money I pay fare and come, otherwise I walk...Walking
from (place name) to Mweso takes four hours. It takes
will power to come because of the expenses. It’s a long
distance. It takes sacrifice because I never want to miss
my appointment. " (P06, male)
Travel to clinic appointments appears to be particu-
larly challenging at times of conflict in the region. North
Kivu is a region of instability, with regular incidences of
violent conflict. During periods of fighting, travel to
Mweso from far distances becomes even more difficult
than usual, if not impossible.
"Some of us come from very far where you need transport
here, for example (place name). Is it possible for you
(MSF) to arrange for us to collect medicine close to where
we come from? Because sometime the roads are blocked
by fighting and medicine is finished and you have an
appointment to come to Mweso and you have no way of
coming. Is there a way you can help us? Because there is
a dispensary at (place name)." (P03, male)
“If they could bring the medicines to (place name of
home village) it would make it easier (collecting
medicines). Because sometimes the roads are bad and
people can get attacked. Like when some people were
attached that time in Au Baibe.” (P02, female)
Sustainable treatment approach
A second theme - Sustainable treatment approach -
emerged predominantly from interviews with staff. The
staff interviewed for this study were eager to discuss
their role in the programme and in following protocols,
and were animated in describing its successes. Pride in
their achievements with the programme appear integral
in creating and maintaining their enthusiasm for con-
tinuing their efforts in the IDC-OPD, despite major chal-
lenges with time and human resources.
" Regarding the support, it has improved a lot.
Because before, when we did not have this clinic,
there were diabetic patients who would arrive
either in hypo/hyperglycaemia, we took them up
only within the boundaries of the little bits of
medication we had available within the ward.
There were some of these drugs that were not
available at the big pharmacy. But since we
started this support, we have seen, I saw, that
there is a follow-up and by the way we are very
happy....I am thankful also because we follow-up
diabetic pregnant women! Really, with the support, I
can see that it is really, 100%, something good. " (S01)
" The quality of care is the best here. When each patient
arrives to the hospital, first of all, he is well welcomed.
We try to test his glucose; we check his weight, his blood
pressure. We try to do a nurse consultation, ask the
patient if he has any particular complaint during his
stay at home. Then....once we see that there a positive
aspect that allows us to judge that the patient can see
the physician for a medical consultation, we guide him
and transfer him to a medical consultation for an
appropriate management. And if we see that the patient
has a stable glucose rate, no particular problem, we the
nurses, we try to conduct the treatment of the patient
and then we provide him with the next appointment of
the Diabetic clinic. (S05)
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At the time of our research, staff had only received one
formal capacity-building session and it had been several
months since this had occurred. Local staff remained
dependent on MSF staff and repeatedly emphasized a de-
sire for further capacity building, suggesting that failure to
deliver such support may result in reduction of motivation
and commitment to the IDC-OPD.
S: "With regards to diet, if the partner (MSF) could
help us with a nutrition programme and nutritionists
available to follow up the patients with us and help
them become more disciplined with their diet, it would
be helpful...Of course, we have the economic problem
because the diet we propose is pricy for the patients. It
is an additional obstacle. "
I:" Thank you very much. Do you have anything to
add or suggest anything to improve the programme?"
S:" OK. It is about our development and continued
education. The activity is quite new and we do need
an on-going training....We need regular updates. If
you (MSF)are conducting such programmes in other
provinces or countries, it would be helpful for us to see
them....The problem we have is that we are not always
confident about what we do. We feel sometimes that we
have a limited knowledge or experience....We have no
clue about our weaknesses when it comes to stabilising
the patient. We still have no solution to that." (S04)
"Thankfully we have the doctors who are here and
helping us try to change...you know, in scientific life, man
cannot stay immobile. Man needs to change. Needs to
get information. And these pieces of information will
help improve the quality of care both from a staff and a
patient's point of view...when man limit ourselves to only
routine, routine, routine, the consequence will not only be
suffered by him, but also by the patient. We are trying to
alter the system! " (S01)
The IDC-OPD programme in Mweso was initiated by
MSF, to respond to the need expressed by both MSF and
MoH staff at Mweso hospital, for support in responding
to increased numbers of DM patients. DRC’s national
policy on DM is only partially implemented and the
country’s framework for monitoring and surveillance of
DM is not routinely implemented and receives little pol-
itical support [25]. The MoH looks to MSF for guidance
on programme protocols and there appears to be no
initiative on the part of MoH to take responsibility for
further development of protocols or capacity-building
programmes. This dependence on MSF appears to create
insecurity among staff about the future of the
programme, given the uncertainty about the duration of
MSF’s presence in the region.
"For example, we need to know specifically that the
programme will last one or two years, or more… If we
have this guarantee, we have visibility and we can
come up with a plan to control and manage the
patients. We would know what to share with the
patients. Sometimes we have reserves regarding the
education, because we project things in the future. We
say, for example: “next year or the next six months you
will be this and that and you will have to do this and
that… “ While even us, we don’t have the guarantee
that the programme will be there to help the patient
and do a proper follow-up. "(S02)
Discussion
A review of the literature suggests that this is the first
study to identify factors that impede or support the
effectiveness of the DM programme in a complex
humanitarian setting in Sub-Saharan Africa. Two over-
arching themes – community awareness, knowledge, and
family support; and sustainable treatment approach –
emerged and highlighted factors that may promote or
impede the reach, efficacy, adoption, implementation,
and maintenance of the IDC-OPD model.
The first of these themes points to the importance of
community awareness to the effectiveness of DM inter-
ventions. These findings are consistent with existing evi-
dence from LMICs highlighting the importance of
community awareness for improving not only the reach of
evidence-based interventions such as HIV [26], breast
cancer [27], and cervical cancer [28] screening, but also
the efficacy, adoption, and maintenance of HIV interven-
tions through community mobilisation, or the involve-
ment of the community in the planning, implementation,
and ownership of the intervention to ensure its relevance
and accessibility [29].
Our findings also emphasize the value of treatment
support, including psychosocial and educational support
to DM patients and their families, and culturally sensi-
tive, low-cost dietary advice, to ensuring the adoption
and maintenance of DM treatment. Patient and family
psycho-social support and education have proven to be
integral to ensuring acceptance of long-term or chronic
illnesses and persistent adherence to medication. The
recent experience of MSF in Kenya with Medical Adher-
ence Clubs for NCD and HIV patients (groups of pa-
tients who meet every 3 months to collect pre-packaged
prescription medicines, engage in health education and
discussion and have their weight and blood pressure
measured) suggests that such models of care are accept-
able to patients and staff, who perceive them as time-
saving [30]. Likely the largest body of evidence of the
effectiveness of psychosocial education and support
comes from research on HIV and TB, where community
patient groups [31], social support [32], and patient and
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family education activities [30, 33] have been found to
improve treatment adoption and maintenance. New
interventions that adapt these lessons to NCD pro-
grammes in LMIC are being trialled. For example, the
IMPACT-AF trial [34] is testing the effectiveness of a
customized intervention for increasing adherence to
therapy among patients with atrial fibrillation (a major
risk factor for stroke) in five LMICs. In India the inter-
vention will involve training non-physician health
workers to educate patients in AF and symptoms of
stroke, and the importance of adhering to medication to
prevent stroke, while identifying non-adherent patients
and addressing the barriers to adherence that they
experience. Diaries are given to patients to allow them
to record days when they take medications, and included
educational content. While these interventions are cur-
rently being implemented in non-crisis-affected settings,
the results of their evaluations will nonetheless be rele-
vant to most contexts where patient knowledge is low
and access to health facilities and highly-trained physi-
cians is difficult.
Similarly, dietary restrictions have been identified as a
potential barrier to adhering to antiretroviral therapy,
[35] in particular in the context of food insecurity [36].
Specific to DM, research from low-income populations
in higher-income countries such as the USA suggest that
limited food environments, limited and abstract commu-
nication from clinicians, short term losses vs. gains and
stress from poverty all contributed to low adherence to
DM dietary regimes in these contexts, and highlight the
need for customized dietary advice [37].
While our findings are consistent with evidence from
non-crisis-affected low-income settings, they also con-
tribute to this body of knowledge by identifying specific
factors that may be particularly important to consider in
complex humanitarian emergencies. Our findings re-
garding the challenges faced by patients in accessing
treatment regularly highlight two elements that may
ensure successful adoption, implementation, and main-
tenance of a DM or other chronic NCD treatment
programme - decentralization of treatment provision
and reduced appointment frequency. These factors are
relevant to any setting where health facilities are distant
and difficult to reach, but as shown in our interviews, in
conflict-affected settings, when faced with the possibility
of travelling through conflict zones, patients opt to
forego treatment. Lessons from research on adherence
to antiretroviral treatment for HIV provides useful
lessons, suggesting that community-based care models
are effective in reducing patient attrition [38, 39].
The second overarching theme that emerged from our
interviews – Sustainable treatment approach – is rele-
vant to many development contexts, where local owner-
ship and capacity-building have been identified as vital
to ensuring health systems strengthening and sustain-
ability of health programmes [40]. With DM specifically,
these factors may have a greater impact on treatment ac-
cess than do issues of pure affordability and availability
of medicine [41]. Our findings support the argument
that ensuring a sustainable treatment approach through
local programme ownership and capacity building is also
important to consider in complex humanitarian emer-
gencies, where interventions are initially implemented
and then heavily supported by humanitarian agencies
such as MSF. Agencies acting in humanitarian crises
traditionally keep ‘beneficaries’ as their unique target
group, rather than health systems, As such, there are
times when they do not work within the health system
at all (e.g. such as when, for example, MSF responds to a
cholera outbreak in South Sudan where the health sys-
tem is essentially absent). However, our findings suggest
that where impact for beneficiaries would be increased
through engagement with the health system, such as in
chronic disease programmes (HIV, NCDs) in protracted
crises, meaningful engagement with the health system is
necessary to ensure sustainability. These findings reflect
current discussion around the role of humanitarian
agencies in health systems strengthening, and specifically
how to balance achievement of quick results with longer-
term maintenance of health programmes [42–44]. While
strong arguments exist for the value of longer-term think-
ing in the case of NCD interventions in complex humani-
tarian emergencies [45], thus far little guidance exists as
to how to realize these concepts in such settings. Some
lessons can be drawn from successful experiences of MSF
and others in the treatment of HIV [46]. Effective strat-
egies may include: ensuring staff (including MoH staff)
have a solid grounding in the basics of disease manage-
ment through regular trainings; establishing partnerships
with local government and other health authorities, gov-
erned by memoranda of understanding, to integrate the
programme with other health services, including with
drug supply chains; ensuring buffer stocks of drugs ra-
ther than outright provision; and scale-up and incorp-
oration of successful programme elements into national
guidelines, as has been recommended with community
ART distribution programmes for HIV [47, 48].
Limitations
Our findings should be interpreted in light of some limita-
tions. First, we were only able to recruit patients that were
present at the clinic in the period that the study took
place. As such, the findings may not be generalizable to
those with DM who did not come to the clinic in that
period. These individuals may have shared important
information on barriers to adherence to treatment. How-
ever, these themes are also likely to have been captured in
the data from included patients, as some of these had at
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some point not regularly kept appointments or adhered to
treatment. Data from interviews with staff, who interacted
with and observed the behaviour of all registered DM pa-
tients, would also have shed light on barriers experienced
by non-adherent patients. Second, it is possible that inter-
viewed patients or staff may have responded to our inter-
view questions with what they believed to be the response
that the interviewer wanted to hear. However, we feel that
this is unlikely, as it was made clear to all participants that
neither of the interviewers (AM and MB) were involved in
design or provision of the DM programme and all parti-
pants appeared to respond openly and naturally during
the interviews. Finally, while the themes that we found
may be generalizable to the larger population served by
this programme or other similar contexts, they may not
generalize to DM programmes in dissimilar settings.
Conclusion
Our study suggests that the effectiveness of treatment
models for DM in complex humanitarian emergencies
can be improved by addressing community awareness,
patient, and family knowledge and psychosocial support,
appropriateness of dietary guidelines, decentralization of
treatment and ownership and capacity-building of local
staff. Our findings highlight the potential role agencies
acting in humanitarian crises can play in supporting
local health systems to ensure sustainability of health
care delivery for chronic conditions. While the factors
that we identified in our study are similar to those that
are relevant in any low-income setting, they are of
particular importance where access to health facilities is
impeded and implementing agencies are only present in
the short-term. Although our findings are specific to the
MSF-implemented IDC-OPD, they provide important in-
sights that are likely to be applicable to NCD interventions
in other similar contexts.
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